592 related articles for article (PubMed ID: 25970812)
1. Higher nocturnal and awake oxygen saturations in children with sickle cell disease receiving hydroxyurea therapy.
Narang I; Kadmon G; Lai D; Dhanju S; Kirby-Allen M; Odame I; Amin R; Lu Z; Al-Saleh S
Ann Am Thorac Soc; 2015 Jul; 12(7):1044-9. PubMed ID: 25970812
[TBL] [Abstract][Full Text] [Related]
2. Higher oxygen saturation with hydroxyurea in paediatric sickle cell disease.
van Geyzel L; Arigliani M; Inusa B; Singh B; Kozlowska W; Chakravorty S; Bossley CJ; Ruiz G; Rees D; Gupta A
Arch Dis Child; 2020 Jun; 105(6):575-579. PubMed ID: 31871045
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea.
Grady AJ; Hankins JS; Haberman B; Schoumacher R; Stocks RM
Sleep Breath; 2017 Sep; 21(3):697-701. PubMed ID: 28078488
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Salvia AC; Figueiredo MS; Braga JA; Pereira DF; Brighenti FL; Koga-Ito CY
J Oral Pathol Med; 2013 Aug; 42(7):570-5. PubMed ID: 23278631
[TBL] [Abstract][Full Text] [Related]
6. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease.
Jain DL; Sarathi V; Desai S; Bhatnagar M; Lodha A
Hemoglobin; 2012; 36(4):323-32. PubMed ID: 22734586
[TBL] [Abstract][Full Text] [Related]
7. Early occurrence of obstructive sleep apnea in infants and children with cystic fibrosis.
Spicuzza L; Sciuto C; Leonardi S; La Rosa M
Arch Pediatr Adolesc Med; 2012 Dec; 166(12):1165-9. PubMed ID: 23090511
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of obstructive sleep apnea in children with sickle cell disease at a tertiary hospital in Saudi Arabia.
Al-Otaibi T; Al-Qwaiee M; Faraidi H; Batniji F; Al-Otaibi F; Al-Harbi A
Saudi Med J; 2017 Jun; 38(6):616-620. PubMed ID: 28578441
[TBL] [Abstract][Full Text] [Related]
9. Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.
Ghafuri DL; Chaturvedi S; Rodeghier M; Stimpson SJ; McClain B; Byrd J; DeBaun MR
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035747
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
Creary SE; Gladwin MT; Byrne M; Hildesheim M; Krishnamurti L
Pediatr Blood Cancer; 2014 Jun; 61(6):1068-73. PubMed ID: 24436121
[TBL] [Abstract][Full Text] [Related]
11. Severity of obstructive sleep apnea in children with sickle cell disease.
Kaleyias J; Mostofi N; Grant M; Coleman C; Luck L; Dampier C; Kothare SV
J Pediatr Hematol Oncol; 2008 Sep; 30(9):659-65. PubMed ID: 18776757
[TBL] [Abstract][Full Text] [Related]
12. Changes in Transcranial Doppler Flow Velocities in Children with Sickle Cell Disease: The Impact of Hydroxyurea Therapy.
Adegoke SA; Macedo-Campos RS; Braga JAP; Figueiredo MS; Silva GS
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):425-431. PubMed ID: 29056404
[TBL] [Abstract][Full Text] [Related]
13. Combination of symptoms and oxygen desaturation index in predicting childhood obstructive sleep apnea.
Chang L; Wu J; Cao L
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):365-71. PubMed ID: 23246417
[TBL] [Abstract][Full Text] [Related]
14. [Effect of hydroxyurea on hemoglobin S].
Torres AF; Eberle SE; Sciuccati G; Bonduel M
Medicina (B Aires); 2003; 63(2):140-2. PubMed ID: 12793083
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study to assess the utility of frequent laboratory monitoring of pediatric patients with sickle cell disease on hydroxyurea.
Nevin J; Myers L; Osunkwo I; Kanter J
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e180-4. PubMed ID: 24072249
[TBL] [Abstract][Full Text] [Related]
16. Nocturnal phenotypical features of obstructive sleep apnea (OSA) in asthmatic children.
Gutierrez MJ; Zhu J; Rodriguez-Martinez CE; Nino CL; Nino G
Pediatr Pulmonol; 2013 Jun; 48(6):592-600. PubMed ID: 23203921
[TBL] [Abstract][Full Text] [Related]
17. Polysomnographic characteristics of a referred sample of children with sickle cell disease.
Rogers VE; Lewin DS; Winnie GB; Geiger-Brown J
J Clin Sleep Med; 2010 Aug; 6(4):374-81. PubMed ID: 20726287
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.
Creary S; Zickmund S; Ross D; Krishnamurti L; Bogen DL
BMC Res Notes; 2015 Aug; 8():372. PubMed ID: 26303306
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
